Dr. Weng serves as Medeon’s Vice President of Products. Dr. Weng is responsible for R&D and co-development service assigned by client.
Before joining Medeon, Dr. Weng was a senior scientist and principle investigator at the Industrial Technology Research Institute (ITRI), where he led advanced technology and product development projects for commercialization. Dr. Weng brings over 20 years of experience in cardiovascular, orthopedic, and liver disease treatments as well as cell therapy. He is the inventor/author of more than 30 patents and scientific publications including in high impact factor journals.
Dr. Weng received his M.S. in Biochemical Sciences at the National Taiwan University, and completed his Ph.D. in Materials Sciences and Engineering at the National Tsing-Hua University. He was also a visiting scientist at the Massachusetts Institute of Technology (MIT).